Publicación:
Use of SARS-CoV-2 genomes to estimate the effective reproductive number (RT) in Peru during march – april 2020 [Uso de genomas de SARS-CoV-2 para la estimación del número reproductivo efectivo (RT) en Perú durante marzo y abril del 2020]

Página de artículo simple
dc.contributor.author Romero P.E. es_PE
dc.contributor.author Sánchez-Yupari M. es_PE
dc.contributor.author Montero S. es_PE
dc.contributor.author Tsukayama P. es_PE
dc.date.accessioned 2024-05-30T23:13:38Z
dc.date.available 2024-05-30T23:13:38Z
dc.date.issued 2021
dc.description Este trabajo fue financiado por el Fondo Nacional de Desarrollo Cient?fico y Tecnol?gico y de Innovaci?n Tecnol?gica (Fondecyt-Per?) en el marco del ?Proyecto de Mejoramiento y Ampliaci?n de los Servicios del Sistema Nacional de Ciencia, Tecnolog?a e Innovaci?n Tecnol?gica? [N?mero de contrato 34?2019-FONDECYT-BM-INC. INV.], y por el CONCYTEC-FONDECYT en el marco del concurso ?Proyectos Especiales: Respuesta al COVID-19 2020-01? [n?mero de contrato 046-2020-FONDECYT].
dc.description.abstract The understanding of COVID-19, caused by the SARS-CoV-2, is essential to improve evidence-based public health policies. The effective reproductive number (Rt) in Peru was estimated using information from 113 complete genomes sequenced by the Instituto Nacional de Salud del Perú (INS), available in the GISAID public database. The Rt trend during March and April of 2020 was found to be similar to results from other epidemiological reports. The Rt decreased during the first two weeks of March. Its lowest value was reported during the week after the quarantine began. The Rt increased moderately after the second week of April. The implication of early decisions taken to mitigate the transmission are discussed. Genomic surveillance will be necessary to understand the transmission and evolution of SARS-CoV-2 in Peru, and will complement the epidemiological information. © 2021, Instituto Nacional de Salud. All rights reserved.
dc.description.sponsorship Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - Concytec
dc.identifier.doi https://doi.org/10.17843/rpmesp.2021.382.6417
dc.identifier.scopus 2-s2.0-85113951231
dc.identifier.uri https://hdl.handle.net/20.500.12390/3076
dc.language.iso spa
dc.publisher Instituto Nacional de Salud
dc.relation.ispartof Revista Peruana de Medicina Experimental y Salud Publica
dc.rights info:eu-repo/semantics/openAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject Surveillance (source: MeSH NLM)
dc.subject Bayesian analysis es_PE
dc.subject COVID-19 es_PE
dc.subject Epidemiological models es_PE
dc.subject Genomics es_PE
dc.subject Molecular epidemiology es_PE
dc.subject Nucleotide databases es_PE
dc.subject Peru es_PE
dc.subject Phyloge-nomics es_PE
dc.subject SARS-CoV-2 es_PE
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.03.09
dc.title Use of SARS-CoV-2 genomes to estimate the effective reproductive number (RT) in Peru during march – april 2020 [Uso de genomas de SARS-CoV-2 para la estimación del número reproductivo efectivo (RT) en Perú durante marzo y abril del 2020]
dc.type info:eu-repo/semantics/article
dspace.entity.type Publication
Archivos
Colecciones
1.1 Eventos institucionales
 6.1 Proyectos de investigación científica